💨 Abstract

The Trump administration is imposing new requirements on Novavax's COVID-19 vaccine, causing uncertainty about updates to other vaccines. The FDA is asking Novavax to run a new clinical trial after granting full approval, raising questions about annual strain updates for all COVID-19 vaccines. This comes after disagreements between FDA's vaccine chief and Health Secretary Robert F. Kennedy Jr.,

Courtesy: wtop.com

Summarized by Einstein Beta 🤖